http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2891488-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4c32029b4b557790a8c108a72e9711bc |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-443 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-70 |
| filingDate | 2014-12-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d9962ab9a53290a19b3c9c2aa9fac89b |
| publicationDate | 2015-07-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | EP-2891488-A1 |
| titleOfInvention | Transdermal therapeutic system |
| abstract | 1. Multilayer, drug-containing Transdermal Therapeutic System (TTS) for the delivery of drugs through the skin to the human body.n n n 2.1 In the case of known transdermal therapeutic systems, it is disadvantageous that they tend to smear on the skin due to a lack of cohesion during application and thus adhere unsafe to the skin.n n n 2.2 To improve the cohesion, a TTS (10) has two or more self-adhesive layers (1, 3, 3 ', 3' ') and at least one non-self-adhesive, tension-resistant and active substance-permeable intermediate layer (2, 2', 2 ''); said adhesive layers and intermediate layer (s) are alternately arranged and bonded together.n n n 2.3 Multilayer TTS is suitable for the delivery of pharmaceutical active ingredients through the skin for therapeutic purposes. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-102015013452-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019077117-A1 |
| priorityDate | 2014-01-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 92.